BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $18.8B | +6.9% | 11.3% | 6.9% |
| Shareholders' equity (Q2 2026) | $18.8B |
|---|---|
| YoY | +6.9% |
| 5-year CAGR | 11.3% |
| 10-year CAGR | 6.9% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $18.3B | +9.2% |
| 2024 | $16.7B | +13.0% |
| 2023 | $14.8B | +10.5% |
| 2022 | $13.4B | +23.0% |
| 2021 | $10.9B | +1.8% |
| 2020 | $10.7B | −19.8% |
| 2019 | $13.3B | +2.3% |
| 2018 | $13.0B | +3.4% |
| 2017 | $12.6B | +3.9% |
| 2016 | $12.1B | +29.5% |
| 2015 | $9.4B | −13.3% |
| 2014 | $10.8B | +25.4% |
| 2013 | $8.6B | +23.8% |
| 2012 | $7.0B | +8.3% |
| 2011 | $6.4B | +19.1% |
| 2010 | $5.4B | −13.3% |
| 2009 | $6.2B | +7.2% |
| 2008 | $5.8B | +4.5% |
| 2007 | $5.6B | — |